This inventor holds 1 USPTO granted patent. Top assignees: Sortera Technologies, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2025.
Company Filing History:
1 out of 23 
1 out of 3,688 
Years Active: 2025
Title: The Innovative Contributions of Stavroula Mili
Introduction
Stavroula Mili is a prominent inventor based in Bethesda, MD (US). She has made significant strides in the field of cancer treatment through her innovative research and development. Her work focuses on utilizing antisense oligonucleotides to combat metastatic cancer, showcasing her commitment to advancing medical science.
Latest Patents
Stavroula Mili holds a patent for "RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER." This patent represents her groundbreaking approach to targeting cancer cells, which could potentially lead to more effective treatments for patients suffering from this devastating disease. She has 1 patent to her name, reflecting her dedication to innovation in the medical field.
Career Highlights
Mili is currently associated with Sortera Technologies, Inc., where she continues to contribute her expertise in developing novel therapeutic strategies. Her role at the company allows her to collaborate with other professionals in the field, further enhancing her impact on cancer research and treatment.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Stavroula Mili's contributions to the field of cancer treatment through her innovative patent work exemplify her dedication to improving patient outcomes. Her ongoing efforts at Sortera Technologies, Inc. highlight her role as a key player in the advancement of medical science.